Clinical Trial Update: Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors [NA]

View source ↗

Summary

Completed clinical trial evaluating Yttrium-90 glass microspheres PET/CT imaging in patients with primary malignant liver neoplasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Liver Neoplasm

Drugs mentioned

• Yttrium-90 glass microspheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Stanford University | Conditions: Primary Malignant Liver Neoplasm | NA | Status: COMPLETED | Results posted: 2021-09-09